Prof Marek Trněný at ASH 2014: Phase II SPRINT study of lenalidomide in relapsed/refractory mantle cell lymphoma

At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Marek Trněný (Charles University Hospital, Prague, Czech Republic) discusses the phase 2 SPRINT (MCL-002) study of lenalidomide ve... Author: EMJ Added: 03/29/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts